The orthopedics industry's technology landscape is being transformed by surgical robotics, artificial intelligence, smart implants, 3D printing, advanced biologics, and augmented reality navigation. The companies that master the integration of these technologies into commercially viable, reimbursable, and clinically superior products will define the competitive hierarchy of the 2030s.

Stryker's Mako demonstrated that robotics enables premium implant pricing, increases procedure volume, and creates durable customer loyalty — Stryker generated $22.6 billion in 2025 revenue with Mako installations exceeding 2,000 systems globally. Globus Medical's ExcelsiusGPS demonstrated that robotics leadership in spine can transform a company's competitive position in two to three years. Zimmer Biomet's ROSA, Johnson & Johnson DePuy Synthes's VELYS, and Smith & Nephew's CORI Surgical System represent the competing robotic platforms reshaping joint replacement economics. The technology integration race in orthopedics is now a company-defining strategic imperative.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.

Emerging Technologies Assessed in This Report Include:
• Surgical Robotics — Mako, ROSA, ExcelsiusGPS, VELYS, CORI competitive race
• AI and Machine Learning — surgical planning, outcomes prediction, workflow optimization
• Smart Implants and Sensors — post-operative monitoring and patient data
• 3D Printing and Patient-Specific Implants — custom manufacturing at scale
• Bone Healing and Regeneration — advanced biologics and growth factors
• Imaging and Navigation — augmented reality surgical guidance
• Wear and Fixation Technology — next-generation materials and coatings
• Soft Tissue Repair — sports medicine and biologic integration

Companies Analyzed in This Report:
Aesculap
Arthrex
DePuy Synthes
Enovis
Globus Medical
NuVasive
Smith & Nephew
Stryker
Wright Medical
Zimmer Biomet

The Analysis of Each Company Includes:
• Strategic Directions and Corporate Priorities
• Financial Performance and Revenue Breakdown
• SWOT Analysis
• Technology and Innovation Programs
• M&A, Partnerships and Alliances
• Market Positioning and Competitive Strategy
• Integration Roadmap and 2030 Outlook

Topics Covered
• Surgical Robotics and Digital Surgery Integration
• Spine and Extremities Portfolio Expansion
• Biologics and Regenerative Medicine Programs
• Value-Based Care and Bundled Payment Strategy
• Emerging Market Expansion — Asia-Pacific, Latin America, Middle East
• M&A and Partnership Activity 2023–2026
• Commercial Strategy and GPO/IDN Contracting
• Strategic Conclusions and Recommendations